Fairvoy Private Wealth
IBB icon

Fairvoy Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Fairvoy Private Wealth’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$373K Sell
1,774
-2,452
-58% -$492K 0.08% 154
2026
Q2 		$804K Sell
4,226
-5,739
-58% -$986K 0.16% 116
2026
Q1 		$1.68M Buy
+9,965
New +$1.7M 0.4% 62

Other funds holding IBB

Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return
Generali Investments CEE
Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return
MinichMacGregor Wealth Management
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return
Investment House LLC
Investment House LLC Redondo Beach, California $2.25B AUM 30.44% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
NTV Asset Management
NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
Redstone Wealth Management
Redstone Wealth Management Oklahoma City, Oklahoma $159M AUM 31.94% 1-Year Est. Return
Folger Nolan Fleming Douglas Capital Management
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.18B AUM 27.44% 1-Year Est. Return
Decker Retirement Planning
Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

Fairvoy Private Wealth's IBB Position: Q3 2026 in Review

Fairvoy Private Wealth reduced its iShares Biotechnology ETF (IBB) stake by 58% in Q3 2026, selling an estimated $492K and leaving 1,774 shares worth $373K. The position accounts for 0.08% of the portfolio, ranked #154.

Fairvoy Private Wealth first reported a position in IBB in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.68M in Q1 2026. 303 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Fairvoy Private Wealth held 1,774 shares of iShares Biotechnology ETF worth $373K as of Q3 2026.
  • Fairvoy Private Wealth sold 2,452 iShares Biotechnology ETF shares in Q3 2026, an estimated $492K.
  • iShares Biotechnology ETF made up 0.08% of Fairvoy Private Wealth's portfolio in Q3 2026, its #154 holding.
  • Fairvoy Private Wealth first reported a position in iShares Biotechnology ETF in Q1 2026 and has held it in 3 quarters since.
  • Fairvoy Private Wealth's iShares Biotechnology ETF position peaked at $1.68M in Q1 2026.
  • 303 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Fairvoy Private Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.